HEADER TRANSFERASE 08-FEB-21 7LNX TITLE I146A MUTANT OF THE ISOPENTENYL PHOSPHATE KINASE FROM CANDIDATUS TITLE 2 METHANOMETHYLOPHILUS ALVUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOPENTENYL PHOSPHATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IPK; COMPND 5 EC: 2.7.4.26; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: I146A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDATUS METHANOMETHYLOPHILUS ALVUS; SOURCE 3 ORGANISM_TAXID: 1291540; SOURCE 4 GENE: BKD89_07040; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHOTRANSFERASE ATP BIOCATALYSIS ISOPRENOIDS ENZYME PROMISCUITY, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.M.THOMAS,S.SINGH,B.P.JOHNSON REVDAT 4 22-MAY-24 7LNX 1 REMARK REVDAT 3 02-FEB-22 7LNX 1 JRNL REVDAT 2 29-DEC-21 7LNX 1 JRNL REVDAT 1 22-DEC-21 7LNX 0 JRNL AUTH B.P.JOHNSON,V.KUMAR,E.M.SCULL,L.M.THOMAS,C.R.BOURNE,S.SINGH JRNL TITL MOLECULAR BASIS FOR THE SUBSTRATE PROMISCUITY OF ISOPENTENYL JRNL TITL 2 PHOSPHATE KINASE FROM CANDIDATUS METHANOMETHYLOPHILUS ALVUS JRNL TITL 3 . JRNL REF ACS CHEM.BIOL. V. 17 85 2022 JRNL REFN ESSN 1554-8937 JRNL PMID 34905349 JRNL DOI 10.1021/ACSCHEMBIO.1C00655 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 22731 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.257 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.4200 - 5.5400 0.99 1620 156 0.2310 0.2679 REMARK 3 2 5.5300 - 4.3900 1.00 1536 148 0.2073 0.2612 REMARK 3 3 4.3900 - 3.8400 1.00 1515 147 0.2155 0.2680 REMARK 3 4 3.8400 - 3.4900 1.00 1502 145 0.2269 0.2817 REMARK 3 5 3.4900 - 3.2400 1.00 1500 145 0.2646 0.3354 REMARK 3 6 3.2400 - 3.0500 1.00 1480 142 0.2792 0.3252 REMARK 3 7 3.0500 - 2.9000 1.00 1468 142 0.2744 0.3657 REMARK 3 8 2.9000 - 2.7700 1.00 1498 144 0.2866 0.3822 REMARK 3 9 2.7700 - 2.6600 1.00 1470 142 0.2882 0.3485 REMARK 3 10 2.6600 - 2.5700 1.00 1475 142 0.2992 0.4040 REMARK 3 11 2.5700 - 2.4900 1.00 1457 141 0.3070 0.3364 REMARK 3 12 2.4900 - 2.4200 0.99 1478 143 0.3057 0.3742 REMARK 3 13 2.4200 - 2.3600 0.97 1420 137 0.3209 0.3916 REMARK 3 14 2.3600 - 2.3000 0.90 1312 126 0.3233 0.4212 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.359 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.772 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3809 REMARK 3 ANGLE : 0.534 5129 REMARK 3 CHIRALITY : 0.042 578 REMARK 3 PLANARITY : 0.003 654 REMARK 3 DIHEDRAL : 14.810 558 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LNX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254680. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22800 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 39.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.69100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5 28% PEG 3350. REMARK 280 0.1 M SODIUM CHLORIDE, VAPOR DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.28250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.46500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.63850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.46500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.28250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.63850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 LYS A 194 REMARK 465 LYS A 195 REMARK 465 LEU A 196 REMARK 465 ASP A 197 REMARK 465 GLU A 198 REMARK 465 ALA A 199 REMARK 465 LEU A 200 REMARK 465 THR A 201 REMARK 465 ASP A 202 REMARK 465 ILE A 203 REMARK 465 THR A 204 REMARK 465 VAL A 205 REMARK 465 ALA A 206 REMARK 465 ASP A 207 REMARK 465 VAL A 208 REMARK 465 THR A 209 REMARK 465 GLY A 210 REMARK 465 GLY A 211 REMARK 465 VAL A 212 REMARK 465 HIS A 213 REMARK 465 SER A 214 REMARK 465 LYS A 215 REMARK 465 MET A 216 REMARK 465 MET A 258 REMARK 465 GLU A 259 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 LYS B 195 REMARK 465 LEU B 196 REMARK 465 ASP B 197 REMARK 465 GLU B 198 REMARK 465 ALA B 199 REMARK 465 LEU B 200 REMARK 465 THR B 201 REMARK 465 ASP B 202 REMARK 465 ILE B 203 REMARK 465 THR B 204 REMARK 465 VAL B 205 REMARK 465 ALA B 206 REMARK 465 ASP B 207 REMARK 465 VAL B 208 REMARK 465 THR B 209 REMARK 465 GLY B 210 REMARK 465 GLU B 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 104 -20.23 -141.78 REMARK 500 ASP A 161 73.64 52.27 REMARK 500 THR A 192 -34.12 -149.80 REMARK 500 ASP A 224 -136.59 -140.55 REMARK 500 CYS B 104 -15.39 -154.45 REMARK 500 LYS B 141 -30.02 -153.38 REMARK 500 ASP B 161 72.11 53.83 REMARK 500 THR B 192 -77.05 -127.43 REMARK 500 ASP B 224 -142.59 -141.21 REMARK 500 ASN B 238 -0.86 66.39 REMARK 500 REMARK 500 REMARK: NULL DBREF1 7LNX A 1 259 UNP A0A3G3II74_9EURY DBREF2 7LNX A A0A3G3II74 1 259 DBREF1 7LNX B 1 259 UNP A0A3G3II74_9EURY DBREF2 7LNX B A0A3G3II74 1 259 SEQADV 7LNX MET A -19 UNP A0A3G3II7 INITIATING METHIONINE SEQADV 7LNX GLY A -18 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER A -17 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER A -16 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -15 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -14 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -13 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -12 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -11 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A -10 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER A -9 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER A -8 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX GLY A -7 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX LEU A -6 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX VAL A -5 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX PRO A -4 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX ARG A -3 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX GLY A -2 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER A -1 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS A 0 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX ALA A 146 UNP A0A3G3II7 ILE 146 ENGINEERED MUTATION SEQADV 7LNX MET B -19 UNP A0A3G3II7 INITIATING METHIONINE SEQADV 7LNX GLY B -18 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER B -17 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER B -16 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -15 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -14 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -13 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -12 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -11 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B -10 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER B -9 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER B -8 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX GLY B -7 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX LEU B -6 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX VAL B -5 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX PRO B -4 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX ARG B -3 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX GLY B -2 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX SER B -1 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX HIS B 0 UNP A0A3G3II7 EXPRESSION TAG SEQADV 7LNX ALA B 146 UNP A0A3G3II7 ILE 146 ENGINEERED MUTATION SEQRES 1 A 279 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 279 LEU VAL PRO ARG GLY SER HIS MET ILE LEU ILE LYS LEU SEQRES 3 A 279 GLY GLY SER VAL ILE THR ASP LYS SER GLU TYR HIS LYS SEQRES 4 A 279 PHE ASN LYS GLU THR VAL SER ARG LEU ALA ASP GLU ILE SEQRES 5 A 279 ARG ARG SER GLY GLN ASP VAL MET VAL VAL HIS GLY ALA SEQRES 6 A 279 GLY SER PHE GLY HIS VAL ILE ALA LYS LYS TYR ALA ILE SEQRES 7 A 279 GLN ASP GLY HIS VAL ASP ASP GLY GLN ILE PRO ALA ALA SEQRES 8 A 279 ALA ARG ILE MET CYS ASP THR ARG GLU LEU SER SER MET SEQRES 9 A 279 VAL VAL GLU GLU LEU LEU ALA GLN GLY ILE PRO ALA VAL SEQRES 10 A 279 SER VAL ALA PRO GLY SER CYS PHE VAL MET GLU ASP GLY SEQRES 11 A 279 LYS LEU ILE VAL ASP ASN GLU GLU PRO ILE ARG ARG LEU SEQRES 12 A 279 ALA ASP LEU GLY ILE MET PRO VAL MET PHE GLY ASP VAL SEQRES 13 A 279 VAL PRO ASP ARG LYS LYS GLY PHE ALA ALA VAL SER GLY SEQRES 14 A 279 ASP GLN CYS MET GLU VAL LEU CYS ARG MET PHE ASP PRO SEQRES 15 A 279 GLU LYS VAL VAL PHE VAL SER ASP ILE ASP GLY LEU TYR SEQRES 16 A 279 THR ALA ASP PRO LYS THR ASP LYS LYS ALA ARG LEU ILE SEQRES 17 A 279 GLY GLU VAL THR ARG LYS LYS LEU ASP GLU ALA LEU THR SEQRES 18 A 279 ASP ILE THR VAL ALA ASP VAL THR GLY GLY VAL HIS SER SEQRES 19 A 279 LYS MET GLU ALA MET LEU ARG MET THR ASP ARG ASN ARG SEQRES 20 A 279 ARG CYS TYR LEU VAL ASN GLY ASN ALA PRO ASN ARG LEU SEQRES 21 A 279 TYR SER LEU LEU LYS GLY GLU THR VAL THR CYS THR VAL SEQRES 22 A 279 ALA LYS GLY GLY MET GLU SEQRES 1 B 279 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 279 LEU VAL PRO ARG GLY SER HIS MET ILE LEU ILE LYS LEU SEQRES 3 B 279 GLY GLY SER VAL ILE THR ASP LYS SER GLU TYR HIS LYS SEQRES 4 B 279 PHE ASN LYS GLU THR VAL SER ARG LEU ALA ASP GLU ILE SEQRES 5 B 279 ARG ARG SER GLY GLN ASP VAL MET VAL VAL HIS GLY ALA SEQRES 6 B 279 GLY SER PHE GLY HIS VAL ILE ALA LYS LYS TYR ALA ILE SEQRES 7 B 279 GLN ASP GLY HIS VAL ASP ASP GLY GLN ILE PRO ALA ALA SEQRES 8 B 279 ALA ARG ILE MET CYS ASP THR ARG GLU LEU SER SER MET SEQRES 9 B 279 VAL VAL GLU GLU LEU LEU ALA GLN GLY ILE PRO ALA VAL SEQRES 10 B 279 SER VAL ALA PRO GLY SER CYS PHE VAL MET GLU ASP GLY SEQRES 11 B 279 LYS LEU ILE VAL ASP ASN GLU GLU PRO ILE ARG ARG LEU SEQRES 12 B 279 ALA ASP LEU GLY ILE MET PRO VAL MET PHE GLY ASP VAL SEQRES 13 B 279 VAL PRO ASP ARG LYS LYS GLY PHE ALA ALA VAL SER GLY SEQRES 14 B 279 ASP GLN CYS MET GLU VAL LEU CYS ARG MET PHE ASP PRO SEQRES 15 B 279 GLU LYS VAL VAL PHE VAL SER ASP ILE ASP GLY LEU TYR SEQRES 16 B 279 THR ALA ASP PRO LYS THR ASP LYS LYS ALA ARG LEU ILE SEQRES 17 B 279 GLY GLU VAL THR ARG LYS LYS LEU ASP GLU ALA LEU THR SEQRES 18 B 279 ASP ILE THR VAL ALA ASP VAL THR GLY GLY VAL HIS SER SEQRES 19 B 279 LYS MET GLU ALA MET LEU ARG MET THR ASP ARG ASN ARG SEQRES 20 B 279 ARG CYS TYR LEU VAL ASN GLY ASN ALA PRO ASN ARG LEU SEQRES 21 B 279 TYR SER LEU LEU LYS GLY GLU THR VAL THR CYS THR VAL SEQRES 22 B 279 ALA LYS GLY GLY MET GLU HET ADP A 501 27 HET Y7D A 502 17 HET ADP B 301 27 HET GOL B 302 6 HET WOG B 303 13 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM Y7D (2Z)-3-METHYLHEPT-2-EN-1-YL TRIHYDROGEN DIPHOSPHATE HETNAM GOL GLYCEROL HETNAM WOG (2E)-3-METHYLHEPT-2-EN-1-YL DIHYDROGEN PHOSPHATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 4 Y7D C8 H18 O7 P2 FORMUL 6 GOL C3 H8 O3 FORMUL 7 WOG C8 H17 O4 P FORMUL 8 HOH *54(H2 O) HELIX 1 AA1 GLY A 7 THR A 12 1 6 HELIX 2 AA2 ASN A 21 GLY A 36 1 16 HELIX 3 AA3 ALA A 45 PHE A 48 5 4 HELIX 4 AA4 GLY A 49 ALA A 57 1 9 HELIX 5 AA5 ILE A 58 GLY A 61 5 4 HELIX 6 AA6 GLY A 66 GLN A 92 1 27 HELIX 7 AA7 ALA A 100 CYS A 104 5 5 HELIX 8 AA8 GLU A 117 LEU A 126 1 10 HELIX 9 AA9 SER A 148 ASP A 161 1 14 HELIX 10 AB1 ASN A 238 LYS A 245 1 8 HELIX 11 AB2 GLY B 7 THR B 12 1 6 HELIX 12 AB3 ASN B 21 GLY B 36 1 16 HELIX 13 AB4 ALA B 45 PHE B 48 5 4 HELIX 14 AB5 GLY B 49 ALA B 57 1 9 HELIX 15 AB6 ILE B 58 GLY B 61 5 4 HELIX 16 AB7 GLY B 66 GLN B 92 1 27 HELIX 17 AB8 ALA B 100 CYS B 104 5 5 HELIX 18 AB9 GLU B 117 GLY B 127 1 11 HELIX 19 AC1 SER B 148 ASP B 161 1 14 HELIX 20 AC2 VAL B 212 ARG B 221 1 10 HELIX 21 AC3 ASN B 238 GLY B 246 1 9 SHEET 1 AA1 6 VAL A 39 HIS A 43 0 SHEET 2 AA1 6 ILE A 2 LEU A 6 1 N LEU A 6 O VAL A 42 SHEET 3 AA1 6 LYS A 164 SER A 169 1 O VAL A 166 N LEU A 3 SHEET 4 AA1 6 ARG A 228 ASN A 233 1 O TYR A 230 N PHE A 167 SHEET 5 AA1 6 THR A 252 ALA A 254 -1 O ALA A 254 N CYS A 229 SHEET 6 AA1 6 GLU A 190 VAL A 191 1 N VAL A 191 O VAL A 253 SHEET 1 AA2 2 ALA A 96 SER A 98 0 SHEET 2 AA2 2 MET A 129 VAL A 131 1 O VAL A 131 N VAL A 97 SHEET 1 AA3 2 VAL A 106 GLU A 108 0 SHEET 2 AA3 2 LYS A 111 ILE A 113 -1 O ILE A 113 N VAL A 106 SHEET 1 AA4 2 ASP A 135 PRO A 138 0 SHEET 2 AA4 2 PHE A 144 VAL A 147 -1 O ALA A 145 N VAL A 137 SHEET 1 AA5 6 VAL B 39 HIS B 43 0 SHEET 2 AA5 6 ILE B 2 LEU B 6 1 N LEU B 6 O VAL B 42 SHEET 3 AA5 6 LYS B 164 SER B 169 1 O VAL B 166 N LEU B 3 SHEET 4 AA5 6 ARG B 228 ASN B 233 1 O TYR B 230 N PHE B 167 SHEET 5 AA5 6 CYS B 251 ALA B 254 -1 O ALA B 254 N CYS B 229 SHEET 6 AA5 6 GLU B 190 VAL B 191 1 N VAL B 191 O VAL B 253 SHEET 1 AA6 2 ALA B 96 SER B 98 0 SHEET 2 AA6 2 MET B 129 VAL B 131 1 O MET B 129 N VAL B 97 SHEET 1 AA7 2 VAL B 106 GLU B 108 0 SHEET 2 AA7 2 LYS B 111 ILE B 113 -1 O ILE B 113 N VAL B 106 SHEET 1 AA8 2 ASP B 135 ASP B 139 0 SHEET 2 AA8 2 GLY B 143 VAL B 147 -1 O ALA B 145 N VAL B 137 CRYST1 40.565 73.277 166.930 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024652 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013647 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005991 0.00000